BioCentury
ARTICLE | Financial News

Aeglea amends IPO

November 16, 2015 8:00 AM UTC

Aeglea BioTherapeutics Inc., Austin, Texas Business: Cancer, Endocrine/Metabolic Date announced: 2015-11-05 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: UBS; BMO Capital Markets; W...